AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ESPERION THERAPEUTICS said its ETC-216 drug cut heart attack- and stroke-causing fatty artery deposits by 4.2%. Esperion rose after hours following Monday's plunge.
PRICELINE'S Q3 net of 24 cents beat views by 3 cents. Last year it lost 63 cents including items. But the online travel firm sees Q4 net of 2-8 cents vs. views for 11. Shares plunged after hours.
THE JUSTICE DEPT. said ...